By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Adaptive Biotechnologies 

307 Westlake Avenue N
Suite 300
Seattle  Washington  98109  U.S.A.
Phone: 206-659-0067 Fax: 206-659-0667



Company News
Adaptive Biotech And Collaborators Demonstrate Value Of Immunosequencing For Diagnosis Of Cutaneous T-Cell Lymphoma 10/8/2015 11:02:05 AM
Adaptive Biotech Release: World’s Leading Experts To Discuss The Advances Of Immune Profiling In Health And Disease During Unprecedented Conference 9/10/2015 10:26:34 AM
Adaptive Biotech Enters Drug Discovery With Launch of New Company, Adaptive Therapeutics 8/20/2015 5:57:51 AM
23andMe Taps Former Adaptive Biotech Exec as CFO and Head of Ops 8/17/2015 7:18:08 AM
Will New CFO Take Adaptive Biotech Public? 8/11/2015 6:06:02 AM
Adaptive Biotech Welcomes Chad Cohen As Its New Chief Financial Officer 8/10/2015 10:05:47 AM
Adaptive Biotech And Collaborators Demonstrate Importance Of Minimal Residual Disease Measurement In Response Evaluation For Multiple Myeloma 7/15/2015 9:49:53 AM
Seattle’s Adaptive Biotech Will Set Up Shop in New York 7/1/2015 6:29:07 AM
Adaptive Biotech To Present Data From Largest Study To Date Demonstrating Superior Sensitivity And Prognostic Value Of Next-Generation Sequencing-Based Minimal Residual Disease (MRD) Detection In Pediatric Acute Lymphoblastic Leukemia 6/12/2015 7:54:07 AM
Children's Oncology Group/Pediatric Blood And Marrow Transplant Consortium Study Shows Adaptive Biotech' clonoSEQ Minimal Residual Disease (MRD) Test Superior To Flow Cytometry In Predicting Post-Transplant Relapse And Survival In Acute Lymphoblastic Leukemia 6/4/2015 7:26:09 AM